Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,336 results for ""Formoterol Fumarate""

Your Filters

Subject : bronchodilator agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysis.

  • Authors : Hatter L; Medical Research Institute of New Zealand, Wellington, New Zealand .; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Carbon Footprint*

  • Source: The European respiratory journal [Eur Respir J] 2024 Jul 11; Vol. 64 (1). Date of Electronic Publication: 2024 Jul 11 (Print Publication: 2024).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Small Airways Disease Affects Aerosol Deposition in Children with Severe Asthma: A Functional Respiratory Imaging Study.

  • Authors : van den Bosch WB; Department of Pediatrics, Division of Respiratory Medicine and Allergy, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/physiopathology ; Aerosols*

  • Source: Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2024 Dec; Vol. 37 (6), pp. 351-361. Date of Electronic Publication: 2024 Sep 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101475057 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Formulation and evaluation of carrier-based dry powders containing budesonide and arformoterol for inhalation therapy.

  • Authors : Oh DW; Korea United Pharm R&D Center, Gangnam-gu, Republic of Korea.; Choi JH

Subjects: Dry Powder Inhalers*/Dry Powder Inhalers*/Dry Powder Inhalers*/methods ; Asthma*/Asthma*/Asthma*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage

  • Source: Pharmaceutical development and technology [Pharm Dev Technol] 2024 Nov; Vol. 29 (9), pp. 966-975. Date of Electronic Publication: 2024 Oct 23.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9610932 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Real-World Efficacy of Fixed Triple Inhalation Therapy in the Treatment of Moderate COPD Patients (RATIONALE Study).

  • Authors : Südi A; Department of Pulmonology, Semmelweis University, Budapest, Hungary.; Sánta B

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis

  • Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2024 Aug 28; Vol. 19, pp. 1943-1955. Date of Electronic Publication: 2024 Aug 28 Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.

  • Authors : Muro S; Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan. .; Kawayama T

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/blood

  • Source: Respiratory research [Respir Res] 2024 Aug 05; Vol. 25 (1), pp. 297. Date of Electronic Publication: 2024 Aug 05.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study.

  • Authors : Steiropoulos P; Department of Pulmonology, Medical School, Democritus University of Thrace Medical School, University General Hospital of Alexandroupolis, Alexandroupolis, Greece.; Georgatou N

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Beclomethasone*/Beclomethasone*/Beclomethasone*/adverse effects ; Bronchodilator Agents*/Bronchodilator Agents*/Bronchodilator Agents*/administration & dosage

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2024 Jan-Dec; Vol. 18, pp. 17534666241263439.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium: Internet ISSN: 1753-4666

Record details

Read More Add to Saved list
×
Academic Journal

Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update.

  • Authors : D'Urzo AD; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Singh D

Subjects: Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/therapeutic use ; Bronchodilator Agents*/Bronchodilator Agents*/Bronchodilator Agents*/therapeutic use ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/therapeutic use

  • Source: Expert review of respiratory medicine [Expert Rev Respir Med] 2021 Sep; Vol. 15 (9), pp. 1093-1106. Date of Electronic Publication: 2021 Jun 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278196 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.

  • Authors : Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Rabe KF

Subjects: Metered Dose Inhalers*; Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2020 Jan 09; Vol. 15, pp. 99-106. Date of Electronic Publication: 2020 Jan 09 Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.

  • Authors : De Backer W; University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, Wilrijk, 2610 Antwerp, Belgium.; De Backer J

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage ; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*administration & dosage

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2020 Jan-Dec; Vol. 14, pp. 1753466620916990.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium: Internet ISSN: 1753-4666

Record details

Read More Add to Saved list
×
Academic Journal

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.

  • Authors : Martinez FJ; Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, 525 E 68th St, Room M-522, Box 130, New York, NY, 10065, USA. .; Lipworth BJ

Subjects: Severity of Illness Index*; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage ; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*administration & dosage

  • Source: Respiratory research [Respir Res] 2020 May 25; Vol. 21 (1), pp. 128. Date of Electronic Publication: 2020 May 25.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  1,336 results for ""Formoterol Fumarate""